Impact and Insight News blends space, science, technology, and combat sports into one forward-looking newsroom. We report where innovation, discovery, and human intensity intersect. This is where impact creates insight.
Follow us on social media:
Welcome to Science & Technology
Get link
Facebook
X
Pinterest
Email
Other Apps
-
This section covers research breakthroughs, emerging technologies, scientific discoveries, and cultural stories at the intersection of innovation and everyday life.
Adrian Leighton Space Correspondent When objects arrive from outside the Solar System, they do so quietly. They do not announce where they came from or how long they have traveled. They drift in on dark trajectories shaped by stars we will never see with the naked eye. This week, NASA released new close-up images of Comet 3I/ATLAS, the third confirmed visitor from interstellar space, and the pictures offer a rare moment of clarity about a world that does not belong to the Sun. Spacecraft-captured view of comet 3I/ATLAS highlighting the bright central core against a textured background. The images were captured in mid November as 3I/ATLAS passed into a more favorable viewing angle for ground and orbital instruments. The updated visuals show a diffuse coma that appears more traditional than scientists expected based on earlier estimates of its activity. Fine structures in the halo of dust and gas are finally visible, revealing a surprisingly even ...
Nathan Arlow Tech & Future Science Writer Magnetically guided microrobots developed at ETH Zurich. Image credit: ETH Zurich. They swim through blood vessels, crawl along tissue, and carry medicines smaller than a speck of dust. 2025 has quietly become the year of the micro-robot. Once confined to speculative sketches and sci-fi storyboards, these machines now appear in peer-reviewed journals, press releases, and early clinical trials. At ETH Zurich, researchers demonstrated microrobots small enough to slip through capillary models and steer magnetically toward simulated clots. In July, a collaboration between the University of Michigan and Oxford University revealed micro-swimmers that can carry drug payloads through complex fluid environments while maintaining directional control. In September, the U.S. Food and Drug Administration granted Microbot Medical’s Liberty system a 510(k) clearance, marking the first time a company has won formal recogniti...
Elliot Fray Science Reporter Several CRISPR-based treatments for blood disorders and rare genetic diseases have entered broader multi-center evaluations this month, marking a cautious but meaningful expansion in gene-editing research. These trials build on earlier safety studies that demonstrated stable editing in targeted cells, though long-term impacts are still being closely monitored. Stylized CRISPR-Cas9 illustration showing DNA strands being cut. Image credit: Ernesto del Aguila III, National Human Genome Research Institute, NIH (public domain). What the New Trials Are Designed to Measure The expanded studies focus on conditions such as sickle cell disease, beta-thalassemia, and select immune disorders where a single genetic change plays a major role in symptoms. According to publicly available trial protocols, researchers are emphasizing three areas: Editing efficiency: How consistently the CRISPR system edits the intended gene across large p...
Comments
Post a Comment